These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15859012)

  • 1. Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .
    Jeun SS; Kim MC; Kim BS; Lee JM; Chung ST; Oh CH; Lee SY; Choe BY
    Clin Imaging; 2005; 29(1):10-5. PubMed ID: 15859012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
    Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.
    Shimizu H; Kumabe T; Tominaga T; Kayama T; Hara K; Ono Y; Sato K; Arai N; Fujiwara S; Yoshimoto T
    AJNR Am J Neuroradiol; 1996 Apr; 17(4):737-47. PubMed ID: 8730195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
    Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
    Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
    AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy.
    Ishimaru H; Morikawa M; Iwanaga S; Kaminogo M; Ochi M; Hayashi K
    Eur Radiol; 2001; 11(9):1784-91. PubMed ID: 11511902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
    Caivano R; Lotumolo A; Rabasco P; Zandolino A; D'Antuono F; Villonio A; Lancellotti MI; Macarini L; Cammarota A
    Int J Neurosci; 2013 Aug; 123(8):537-43. PubMed ID: 23390934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
    Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
    Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
    Fan G; Sun B; Wu Z; Guo Q; Guo Y
    Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton MR spectroscopy of tumefactive demyelinating lesions.
    Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
    Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo proton magnetic resonance spectroscopy of brain tumors.
    Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
    Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.